Abstract
After their generation from myeloid precursors in bone marrow, eosinophil polymorphonuclear (PMN) leukocytes circulate for a brief period in peripheral blood and then emigrate to tissue pools localized predominantly in the lungs, skin, intestines and genitourinary tract (Hudson, 1968; Spry, 1971; Zucker-Franklin, 1974). An increase in the level of eosinophils in peripheral blood and in involved tissues is a prominent feature of systemic immediate hypersensitivity reactions (Campbell et al, 1935). The selective influx of eosinophils to the focus of an immediate hypersensitivity reaction is governed by the tissue levels of diverse eosinophil chemotactic factors, by the biodegradation or inhibition of the chemotactic factors, and by reversible and irreversible alterations in the chemotactic responsiveness of the target cells (Goetzl et al, 1975). The net effect of this series of interactions is the positioning of a critical number of eosinophils at the site of an immediate hypersensitivity reaction so that they may exercise their specific regulatory role (Goetzl et al, 1975).
supported by grants AI-07722 and AI-10356 from the National Institutes of Health.
Investigator, Howard Hughes Medical Institute.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Archer, R.K. 1956. The eosinophilic response in the horse to intramedullary and intradermal injections of histamine, ACTH, and cortisone. J. Pathol. Bact. 72:87.
Berenberg, J.A., and Ward, P.A. 1973. Chemotactic factor inactivator in normal human serum. J. Clin. Invest. 52:1200.
Bokisch, V.A., and Müller-Eberhard, H.J. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427
Campbell, A.C.P., Drennan, A.M., and Rettie, R. 1935. The relationship of the eosinophile leukocyte to allergy and anaphylaxis. J. Path. Bact. 40:537.
Clark, R.A.F., Gallin, J.I., and Kaplan, A.P. 1975. The selective eosinophil chemotactic activity of histamine. J. Exp. Med. 142:1462.
Goetzl, E.J. 1975. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann. N.Y. Acad. Sci. 256:210.
Goetzl, E.J., and Austen, K.F. 1972. A neutrophil immobilizing factor derived from human leukocytes. I, Generation and partial characterization. J. Exp. Med. 136:1564.
Goetzl, E.J., and Austen, K.F. 1974. Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J. Clin. Invest. 53:591.
Goetzl, E.J., and Austen, K.F. 1975. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. USA 72:4123.
Goetzl, E.J., Gigli, I., Wasserman, S.I., and Austen, K.F. 1973. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J. Immunol. 111:938.
Goetzl, E.J., Wasserman, S.I., Gigli, I., and Austen, K.F. 1974a. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. Clin. Invest. 53:813.
Goetzl, E.J., Wasserman, S.I., and Austen, K.F. 1974b. Modulation of the eosinophil chemotactic response in immediate hypersensitivity. In: Progress In Immunology II, L. Brent and J. Holborow, eds., vol. 4, North-Holland Publishing Co., Amsterdam, p. 41.
Goetzl, E.J., Wasserman, S.I., and Austen, K.F. 1975. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch. Pathol. 99:1.
Goetzl, E.J., Boswell, R.N., and Austen, K.F. 1976a. The tetrapeptides comprising eosinophil chemotactic factor of anaphylaxis (ECF-A): Structural determinants of chemotactic activity. Fed. Proc. (abstract), in press.
Goetzl, E.J., Rubin, R.H., McDonough, J., Tashjian, A.H., Jr., Austen, K.F. 1976b. Production of eosinophilotactic peptides by bronchogenic carcinoma jin situ and in vitro. Clin. Res. (abstract), in press.
Hudson, G. 1968. Quantitative study of the eosinophil granulocytes. Semin. Hematol. 5:166.
Kaliner, M.A., Wasserman, S.I., and Austen, K.F. 1973. The immunologic release of chemical mediators from human nasal polyps. N. Engl. J. Med. 289:277.
Kay, A.B., and Austen, K.F. 1971. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J. Immunol. 107:899.
Kay, A.B., Shin, H.S., and Austen, K.F. 1973. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology 24:969.
Kay, A.B., Stechschulte, D.J., and Austen, K.F. 1971. An eosinophil leukocyte chemotactic factor of anaphylaxis. J. Exp. Med. 133:602.
Lewis, R.A., Goetzl, E.J., Wasserman, S.I., Valone, F.H., Rubin, R.H., and Austen, K.F.: The release of four mediators of immediate hypersensitivity from human leukemic basophils. J. Immunol. 114:87.
McKenzie, R., Pepper, D.S., and Kay, A.B. 1975. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen. Thrombosis Res. 6:1.
Najjar, V.A. 1974. The physiological role of γ-globulin. Advan. Enzymol. 41:129.
Nishioka, K., Constantopoulos, A., Satoh, P.S., and Najjar, V.A. 1972. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide Tuftsin. Biochem. Biophys. Res. Commun. 47:172.
Parish, W.E. 1970. Investigations on eosinophilia. The influence of histamine, antigen-antibody complexes containing γl or γ2 globulins, foreign bodies (phagocytosis) and disrupted mast cells. Brit. J. Dermatol. 82:42.
Snyderman, R., Shin, H.S., and Hausman, M.H. 1971. A chemotactic factor for mononuclear leukocytes. Proc. Soc. Exp. Biol. Med. 138:387.
Spry, C.J.F. 1971. Mechanism of eosinophilia: V. Kinetics of normal and accelerated eosinopoiesis. Cell Tissue Kinet. 4:351.
Torisu, M., Yoshida, T., Ward, P.A., and Cohen, S. 1973. Lymphocyte-derived eosinophil chemotactic factor: II. Studies on the mechanism of activation of the precursor substance by immune complexes. J. Immunol. 111:1450.
Turner, S.R., Campbell, J.A., and Lynn, W.S. 1975. Polymorphonuclear leukocyte Chemotaxis toward oxidized lipid components of cell membranes. J. Exp. Med. 141:1437.
Vallota, E.H., and Müller-Eberhard, H.J. 1973. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J. Exp. Med. 137:1109.
Vaughn, J. 1953. The function of the eosinophile leukocyte. Blood 8:1.
Vegad, J.L. and Lancaster, M.C. 1972. Eosinophil leukocyteattracting effect of histamine in the sheep skin. Indian J. Exp. Biol. 10:147.
Ward, P.A. 1967. A plasmin-split fragment of C3 as a new chemotactic factor. J. Exp. Med. 126:189.
Ward, P.A. 1971. Complement-derived leukotactic factors in pathological fluids. J. Exp. Med. 134:1095.
Ward, P.A., and Becker, E.L. 1968. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. Exp. Med. 127:693.
Ward, P.A., and Becker, E.L. 1970. Biochemical demonstration of the activatable esterase of the rabbit neutrophil involved in the chemotactic response. J. Immunol. 105:1057.
Ward, P.A., and Hill, J.H. 1970. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104:535.
Wasserman, S.I., Goetzl, E.J., Kaliner, M.A., and Austen, K.F. 1974a. Modulation of the immunologic release of the eosinophil chemotactic factor of anaphylaxis from human lung. Immunology 26:677.
Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1974b. Preformed eosinophil chemotactic factor of anaphylaxis. J. Immunol. 112:351.
Wasserman, S.I., Goetzl, E.J., Ellman, L., and Austen, K.F. 1974c. Tumor-associated eosinophilotactic factor. N. Engl. J. Med. 290:420.
Wasserman, S.I., Whitmer, D., Goetzl, E.J., and Austen, K.F. 1975. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis. Proc. Soc. Exp. Biol. Med. 148:301.
Wasserman, S.I., Boswell, R.N., Drazen, J.M., Goetzl, E.J., and Austen, K.F. 1976. Functional specificity of the human lung acidic tetrapeptides constituting eosinophil chemotactic factor of anaphylaxis (ECF-A). J. Allergy Clin. Immunol., in press.
Zucker-Franklin, D. 1974. Eosinophil function and disorders. Adv. Intern. Med. 19:1.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Goetzl, E.J., Austen, K.F. (1976). Specificity and Modulation of the Eosinophil Polymorphonuclear Leukocyte Response to the Eosinophil Chemotactic Factor of Anaphylaxis (ECF-A). In: Johansson, S.G.O., Strandberg, K., Uvnäs, B. (eds) Molecular and Biological Aspects of the Acute Allergic Reaction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4304-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4304-2_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4306-6
Online ISBN: 978-1-4613-4304-2
eBook Packages: Springer Book Archive